American Journal of Preventive Cardiology
Издатель: Elsevier · ISSN 2666-6677 · 100 статей
- Associations of traumatic brain injury with incident cardiovascular disease: Results from the atherosclerosis risk in communities (ARIC) study
- Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center
- Performance of the PREVENT heart failure risk score and correlation with microvascular dysfunction and coronary plaque burden in patients with rheumatoid arthritis
- Real-world treatment adherence and persistence among patients initiating inclisiran or PCSK9 mAbs
- Implementation of an EHR-supported multidisciplinary lipid management program for suspected familial hypercholesterolemia: Early clinical and implementation outcomes
- The association of Zip Code-level income with cardiovascular disease burden in the Bronx: a two-decade analysis
- Racial/ethnic differences in Life’s Essential 8 and polysocial risk as an effect modifier among women of reproductive age
- Cost-effectiveness of a telephone health coaching and remote exercise monitoring for peripheral artery disease (TeGeCoach)
- Association between the planetary health diet index and risk of cardiovascular diseases in postmenopausal women: Findings from the Women’s Health Initiative Observational Study
- Efficacy and safety of alirocumab once-monthly in patients with atherosclerotic cardiovascular disease and without history of an acute atherothrombotic event
- A bilingual cardiometabolic screening workflow during pediatric well-child visits: early experience from a hispanic-serving primary care clinic
- Effects of PCSK9 inhibitors on coronary atheroma morphology in patients with coronary artery disease treated with statins: a meta-analysis and systematic review
- Evaluating algorithmic fairness in the performance of the AHA PREVENT equations versus pooled cohort equations among single-race and multiracial populations
- Primary results of the VICTORION-NOVEL (LDL-C management Program in atherosclerotic cardiovascular disease patients with elevated LDL-C) lipid optimization multicenter implementation trial
- Neighborhood disadvantage and cardiovascular health in early adolescents in the United States
- Cardiovascular health and depression among postpartum women in the United States
- Scaling a Lipid-Lowering Clinical Decision Support Intervention Across U.S. Health Systems: Lessons Learned from the PROMPT-LIPID Multicenter Study
- Clinical value of the new obesity definition for cardiovascular events in a Middle Eastern population: the TLGS
- Factors associated with patient preferences for statin therapy in primary prevention
- Treatment patterns in homozygous familial hypercholesterolemia: Undertreatment and delayed adoption of low-density lipoprotein receptor–independent therapies
- Study design, rationale, and baseline characteristics of ATTAIN-HYPERTENSION, a phase 3 trial of the oral GLP-1 receptor agonist orforglipron for hypertension
- Circulating PCSK9 as a sex-stratified predictor in primary prevention of cardiovascular disease: Insights from a prospective cohort study in Chinese adults
- Dietary Risks and Cardiometabolic Disease Burden Across the United States: Geographic Inequalities, Age–Period–Cohort Patterns, and Projections to 2045
- Prevalence and trends of risk factors and comorbidities among patients treated for acute myocardial infarction: Insights from the Hungarian Myocardial Infarction Registry, 2014–2024
- Diet patterns are associated with progression of coronary artery calcification and differ across race/ethnicity: The Multi-Ethnic Study of Atherosclerosis
- Reframing the cardiovascular patient as a brain at risk
- Re: Fan J, Hu Y, Zhang J, Chen J, Yuan Y, Yu B. associations between artificial sweeteners and cardiovascular disease, stroke, and diabetes: A Mendelian randomization study. Am J Prev Cardiol 2025;24:101325. DOI: 10.1016/j.ajpc.2025.101325
- Association of reproductive factors with acute myocardial infarction in young women: A VIRGO and NHANES case-control study
- Genetically determined very low lipoprotein(a) is not associated with type 2 diabetes and glycemic traits
- Temporal changes in lipoprotein(a) after acute coronary syndrome